Shares of the biotech Neumora Therapeutics began the first trading day of 2025 with a loss of more than 80% after the company ...

Neumora Therapeutics Inc.’s shares plummeted after the company’s experimental drug failed to show a benefit in a final-stage ...

Duloxetine is an antidepressant, with a specific batch having been recalled due to the presence of potentially cancer-causing impurities.

We’re used to hearing that depression is a chemical problem, one that starts in the brain and can only be fixed with ...

Jan 2 (Reuters) - Neumora Therapeutics' (NMRA.O), opens new tab shares tumbled more than 80% on Thursday after its experimental depression drug failed to reduce symptoms such as sadness and ...

Antidepressants known as selective serotonin reuptake inhibitors, or SSRIs have been the first line of treatment for mood ...

A popular antidepressant, often known by the brand ... The recent recall covered duloxetine drugs made by New Jersey-based company Rising Pharmaceuticals, while an earlier recall in October ...

During pregnancy, a health care provider will generally need to manage two different clinical scenarios: 1) starting medications, either for a woman with new-onset depression or for a woman ...

Clinical trials and meta-analyses reporting increases in depression, anxiety, and suicide led to the swift and stunning ...

Dr. Iregui said taking the drug allowed him to discover new perspectives about his emotions ... resulted in significant reductions in depression among subjects, “measurably greater ...